In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective alpha(1A) receptor antagonists for the treatment of benign prostatic hyperplasia.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples